An interventional study of Valens microencapsulated calcium butyrate and Low FODMAP in Gastrointestinal Symptom, Athletes and FODMAP Diet, sponsored by Universiti Tunku Abdul Rahman. Enrolling by invitation at 1 site in Malaysia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Universiti Tunku Abdul Rahman · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to determine the effectiveness of a low FODMAP diet and microencapsulated oral calcium butyrate supplementation in reducing GI symptoms among athletes in Perak.
Athletes identified with at least one gastrointestinal symptoms according to the Gastrointestinal Symptom Rating Scale (GSRS) and meeting the inclusion criteria will be invited to participate in the intervention study. Following written informed consent and baseline assessment using the GSRS, participants will be randomized in a single-blind manner in a 1:1:1 into Low FODMAP diet, Microencapsulated oral calcium butyrate supplementation (3g/day) or Control group.
Universiti Tunku Abdul Rahman is the lead sponsor of 37 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive individualized dietary counselling to follow a low FODMAP diet for 12 weeks. Compliance will be monitored using 3-day food records at Weeks 4, 8, and 12.
Behavioral: Low FODMAP
Participants will receive microencapsulated oral calcium butyrate supplementation sachet (3g/day) providing 600 mg butyrate for 12 weeks while maintaining their usual dietary intake. Compliance will be monitored through sachet counts and participant self-report.
Dietary Supplement: Valens microencapsulated calcium butyrate
Participants will continue their habitual diet and receive individualized general healthy eating advice for 12 weeks.
Behavioral: Habitual diet and individualized general healthy eating advice
Microencapsulated oral calcium butyrate supplementation sachet (3g/day) providing 600 mg butyrate for 12 weeks while maintaining their usual dietary intake.
Individualized dietary counselling to follow a low FODMAP diet for 12 weeks.
Continue their habitual diet and receive individualized general healthy eating advice for 12 weeks.
Number of athletes with the minimum gastrointestinal symptoms on the Gastrointestinal Symptom Rating Scale (GSRS) score at Week 12
Number of athletes with a total Gastrointestinal Symptom Rating Scale (GSRS) score of 15 at Week 12. The 15-item scale ranges from 15 to 105, lower scores indicate fewer or less severe gastrointestinal symptoms. A score of 15 is the minimum possible total score, indicating no gastrointestinal symptoms.
Time frame: 12 weeks
Change in gastrointestinal symptoms on the Gastrointestinal Symptom Rating Scale (GSRS) total score from baseline to Weeks 4, 8, and 12
Change in total score on the 15-item Gastrointestinal Symptom Rating Scale (GSRS) from baseline (Week 0) to Week - 4, 8, and 12 among Perak athletes. Scores range from 15 to 105, lower scores indicate fewer or less severe gastrointestinal symptoms. A score of 15 is the minimum possible total score, indicating no gastrointestinal symptoms. Change is calculated as the score at each follow-up time point minus the baseline score.
Time frame: Baseline (Week 0) and Week - 4, 8, and 12
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Individual participant data will not be shared because the informed consent and ethics approvals do not authorize the release of participant-level data. The study protocol may be available from the primary investigator on reasonable request.
Start is estimated for Jan 2027; primary completion for Jul 2027, 6 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universiti Tunku Abdul Rahman